AUA2025: Non-Muscle Invasive Bladder Cancer Treatment Dilemmas: The Cases You Face and How Best to Treat Them
AUAUniversity14 Mai 2025

AUA2025: Non-Muscle Invasive Bladder Cancer Treatment Dilemmas: The Cases You Face and How Best to Treat Them

AUA2025: Non-Muscle Invasive Bladder Cancer Treatment Dilemmas: The Cases You Face and How Best to Treat Them CME Available: https://auau.auanet.org/node/43041 At the conclusion of this activity, participants will be able to: 1. Confidently apply updated guidelines to the care of patients with non-muscle-invasive bladder cancer. 2. Risk-stratify patients with non muscle- invasive bladder cancer. 3. Adapt treatment choices depending on risk of disease, including consideration to the availability of bacillus Calmette-Guérin. 4. Counsel and manage patients with bacillus Calmette-Guérin-unresponsive non muscle-invasive bladder cancer, including treatment selection with newly approved agents for BCG-unresponsive disease. 5. Individualize patient surveillance according to risk stratification. 6. Evaluate available urinary bladder cancer biomarkers and where to potentially utilize them in practice to inform management. ACKNOWLEDGEMENTS This educational activity is supported by an independent educational grants from: Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Episoder(426)

AUA2023: Managing Toxicities of Checkpoint Inhibitors: A Urologist’s Guide

AUA2023: Managing Toxicities of Checkpoint Inhibitors: A Urologist’s Guide

AUA2023: Managing Toxicities of Checkpoint Inhibitors: A Urologist’s Guide CME Available: https://auau.auanet.org/node/38322 CME Expiration Date: May, 2024 ACKNOWLEDGEMENTS Independent educational g...

23 Aug 20231h 42min

AUA2023: How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients

AUA2023: How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients

AUA2023: How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients following Local Therapy with Curative Intent CME Available: https://auau.auanet.org/node/38312 CME Expiration ...

16 Aug 20231h 59min

Treatment for Hormone Sensitive Prostate Cancer

Treatment for Hormone Sensitive Prostate Cancer

Treatment for Hormone Sensitive Prostate Cancer CME Available: https://auau.auanet.org/node/38703 Treatment for Hormone Sensitive Prostate Cancer (2023), is an exciting new educational offering to u...

9 Aug 202349min

Update Series (2023) Lesson 21: Management of Chronic Pelvic Pain in Men

Update Series (2023) Lesson 21: Management of Chronic Pelvic Pain in Men

Update Series (2023) Lesson 21: Management of Chronic Pelvic Pain in Men Now in its 42nd installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, f...

2 Aug 202325min

AUA2023: Chemotherapy and Immunotherapy for the Urologist and Advanced Practice Provider

AUA2023: Chemotherapy and Immunotherapy for the Urologist and Advanced Practice Provider

AUA2023: Chemotherapy and Immunotherapy for the Urologist and Advanced Practice Provider CME Available: https://auau.auanet.org/node/38307 CME Expiration Date: May, 2024 ACKNOWLEDGEMENTS Independent...

26 Jul 20231h 57min

AUA2023: Upper-Tract Urothelial Cancer Guidelines

AUA2023: Upper-Tract Urothelial Cancer Guidelines

AUA2023: Upper-Tract Urothelial Cancer Guidelines: An Interactive and Evidence-based Course Highlighting the Full Spectrum of Disease via Case Discussion and Video Presentation CME Available: https:/...

19 Jul 20232h 2min

AUA2023: What the General Urologist Should Know about Care of Transgender Patients

AUA2023: What the General Urologist Should Know about Care of Transgender Patients

AUA2023: What the General Urologist Should Know about Care of Transgender Patients CME Available: https://auau.auanet.org/node/38342 CME Expiration Date: May, 2024 ACKNOWLEDGEMENTS Independent educa...

12 Jul 20231h 52min

AUA2023: Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize Outcomes

AUA2023: Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize Outcomes

AUA2023: Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize Outcomes CME Available: https://auau.auanet.org/node/38287 CME Expiration Date: May, 2024 ACKNOWLEDGEMENTS Indep...

5 Jul 20231h 54min

Populært innen Fakta

fastlegen
dine-penger-pengeradet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
treningspodden
foreldreradet
rss-strid-de-norske-borgerkrigene
rss-sunn-okonomi
jakt-og-fiskepodden
sinnsyn
takk-og-lov-med-anine-kierulf
rss-kunsten-a-leve
gravid-uke-for-uke
merry-quizmas
hverdagspsyken
hagespiren-podcast
smart-forklart
rss-kull
fryktlos
lederskap-nhhs-podkast-om-ledelse
hr-podden-2